Literature DB >> 28665156

Fluency adaptation in speakers with Parkinson disease: a motor learning perspective.

Jason A Whitfield1, Catharine Delong2, Alexander M Goberman1, Michael Blomgren2.   

Abstract

PURPOSE: Fluency adaptation is characterised by a reduction in stuttering-like behaviours over successive readings of the same speech material and is an effect that is typically observed in developmental stuttering. Prominent theories suggest that short-term motor learning associated with practice explain, in part, fluency adaptation. The current investigation examined the fluency adaptation effect in a group of speakers with Parkinson disease (PD) who exhibited stuttering-like disfluencies.
METHOD: Individuals with PD (n = 21) and neurologically healthy controls (n = 19) read a passage five times. Per cent syllables stuttered was measured and calculated for each reading passage. RESULT: Participants in the PD group exhibited significantly more stuttering-like disfluencies than control speakers. Twelve individuals in the PD group exhibited at least three per cent syllable stuttered on at least one reading. Statistical trends revealed that the subgroup of individuals with PD who stuttered exhibited a significant reduction in stuttering moments over the five successive readings.
CONCLUSION: A significant fluency adaptation effect was observed for the group of speakers with PD who exhibited stuttering-like disfluencies. Results of the current study are discussed within the framework of the motor learning hypothesis of fluency adaptation.

Entities:  

Keywords:  Parkinson disease; basal ganglia; fluency adaptation; stuttering

Mesh:

Year:  2017        PMID: 28665156     DOI: 10.1080/17549507.2017.1341549

Source DB:  PubMed          Journal:  Int J Speech Lang Pathol        ISSN: 1754-9507            Impact factor:   2.484


  1 in total

1.  Frequency of speech disruptions in Parkinson's Disease and developmental stuttering: A comparison among speech tasks.

Authors:  Fabiola Staróbole Juste; Fernanda Chiarion Sassi; Julia Biancalana Costa; Claudia Regina Furquim de Andrade
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.